{"title":"假丝酵母菌复合亚型深层感染对9种抗真菌药物的体外敏感性分析。","authors":"Wei Zhang, Minghua Zhan, Na Wang, Jingjing Fan, Xuying Han, Caiqing Li, Jinlu Liu, Jia Li, Yongwang Hou, Xinsheng Wang, Zhihua Zhang","doi":"10.1099/jmm.0.001640","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> The <i>Candida parapsilosis</i> complex can be divided into <i>C. parapsilosis sensu stricto</i>, <i>C. orthopsilosis</i>, and <i>C. metapsilosis</i> subtypes. It is uncommon for drug sensitivity tests to type them.<b>Gap Statement.</b> In routine susceptibility reports, drug susceptibility of <i>C. parapsilosis</i> complex subtypes is lacking.<b>Aim.</b> The aim of this study is to investigate the antifungal susceptibility and clinical distribution characteristics of the <i>C. parapsilosis</i> complex subtypes causing deep infection in patients.<b>Methodology.</b> Non-repetitive strains of <i>C. parapsilosis</i> complex isolated from deep infection from 2017 to 2019 were collected. Species-level identification was performed using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer and confirmed using <i>ITS</i> gene sequencing, when necessary. Antifungal susceptibility testing was performed using the Sensititre YeastOne system method.<b>Results.</b> A total of 244 cases were included in the study, including 176 males (72.13 %, 60.69±13.43 years) and 68 females (27.87 %, 60.21±10.59 years). The primary diseases were cancer (43.44 %), cardiovascular disease (25.00 %), digestive system diseases, (18.44 %), infection (6.97 %), and nephropathy (6.15 %). Strains were isolated from the bloodstream (63.11 %), central venous catheters (15.16 %), pus (6.56 %), ascites (5.74 %), sterile body fluid (5.33 %), and bronchoalveolar lavage fluid (BALF, 4.09 %). Of the 244 <i>C. parapsilosis</i> complex strains, 179 (73.26 %) were identified as <i>C. parapsilosis sensu stricto</i>, 62 (25.41 %) were <i>C. orthopsilosis</i>, and three (1.23 %) were <i>C. metapsilosis</i>. Only one <i>C. parapsilosis sensu stricto</i> strain was resistant to anidulafungin, micafungin, caspofungin, and voriconazole, and it was non-wild-type (NWT) to amphotericin B. Furthermore, six <i>C. parapsilosis sensu stricto</i> strains were resistant to fluconazole, and one was dose-dependent susceptible. Five <i>C. parapsilosis sensu stricto</i> strains were NWT to posaconazole. Only one <i>C. orthopsilosis</i> strain was NWT for anidulafungin, micafungin, caspofungin, fluconazole, voriconazole, amphotericin B, and posaconazole, while the rest of the strains were wild-type.<b>Conclusion.</b> <i>C. parapsilosis sensu stricto</i> was the main clinical isolate from the <i>C. parapsilosis</i> complex in our hospital. Most strains were isolated from the bloodstream. The susceptibility rate to commonly used antifungal drugs was more than 96 %. Furthermore, most of the infected patients were elderly male cancer patients.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":"72 3","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"<i>In vitro</i> susceptibility profiles of <i>Candida parapsilosis</i> species complex subtypes from deep infections to nine antifungal drugs.\",\"authors\":\"Wei Zhang, Minghua Zhan, Na Wang, Jingjing Fan, Xuying Han, Caiqing Li, Jinlu Liu, Jia Li, Yongwang Hou, Xinsheng Wang, Zhihua Zhang\",\"doi\":\"10.1099/jmm.0.001640\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction.</b> The <i>Candida parapsilosis</i> complex can be divided into <i>C. parapsilosis sensu stricto</i>, <i>C. orthopsilosis</i>, and <i>C. metapsilosis</i> subtypes. It is uncommon for drug sensitivity tests to type them.<b>Gap Statement.</b> In routine susceptibility reports, drug susceptibility of <i>C. parapsilosis</i> complex subtypes is lacking.<b>Aim.</b> The aim of this study is to investigate the antifungal susceptibility and clinical distribution characteristics of the <i>C. parapsilosis</i> complex subtypes causing deep infection in patients.<b>Methodology.</b> Non-repetitive strains of <i>C. parapsilosis</i> complex isolated from deep infection from 2017 to 2019 were collected. Species-level identification was performed using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer and confirmed using <i>ITS</i> gene sequencing, when necessary. Antifungal susceptibility testing was performed using the Sensititre YeastOne system method.<b>Results.</b> A total of 244 cases were included in the study, including 176 males (72.13 %, 60.69±13.43 years) and 68 females (27.87 %, 60.21±10.59 years). The primary diseases were cancer (43.44 %), cardiovascular disease (25.00 %), digestive system diseases, (18.44 %), infection (6.97 %), and nephropathy (6.15 %). Strains were isolated from the bloodstream (63.11 %), central venous catheters (15.16 %), pus (6.56 %), ascites (5.74 %), sterile body fluid (5.33 %), and bronchoalveolar lavage fluid (BALF, 4.09 %). Of the 244 <i>C. parapsilosis</i> complex strains, 179 (73.26 %) were identified as <i>C. parapsilosis sensu stricto</i>, 62 (25.41 %) were <i>C. orthopsilosis</i>, and three (1.23 %) were <i>C. metapsilosis</i>. Only one <i>C. parapsilosis sensu stricto</i> strain was resistant to anidulafungin, micafungin, caspofungin, and voriconazole, and it was non-wild-type (NWT) to amphotericin B. Furthermore, six <i>C. parapsilosis sensu stricto</i> strains were resistant to fluconazole, and one was dose-dependent susceptible. Five <i>C. parapsilosis sensu stricto</i> strains were NWT to posaconazole. Only one <i>C. orthopsilosis</i> strain was NWT for anidulafungin, micafungin, caspofungin, fluconazole, voriconazole, amphotericin B, and posaconazole, while the rest of the strains were wild-type.<b>Conclusion.</b> <i>C. parapsilosis sensu stricto</i> was the main clinical isolate from the <i>C. parapsilosis</i> complex in our hospital. Most strains were isolated from the bloodstream. The susceptibility rate to commonly used antifungal drugs was more than 96 %. Furthermore, most of the infected patients were elderly male cancer patients.</p>\",\"PeriodicalId\":16343,\"journal\":{\"name\":\"Journal of medical microbiology\",\"volume\":\"72 3\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medical microbiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1099/jmm.0.001640\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001640","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
In vitro susceptibility profiles of Candida parapsilosis species complex subtypes from deep infections to nine antifungal drugs.
Introduction. The Candida parapsilosis complex can be divided into C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis subtypes. It is uncommon for drug sensitivity tests to type them.Gap Statement. In routine susceptibility reports, drug susceptibility of C. parapsilosis complex subtypes is lacking.Aim. The aim of this study is to investigate the antifungal susceptibility and clinical distribution characteristics of the C. parapsilosis complex subtypes causing deep infection in patients.Methodology. Non-repetitive strains of C. parapsilosis complex isolated from deep infection from 2017 to 2019 were collected. Species-level identification was performed using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer and confirmed using ITS gene sequencing, when necessary. Antifungal susceptibility testing was performed using the Sensititre YeastOne system method.Results. A total of 244 cases were included in the study, including 176 males (72.13 %, 60.69±13.43 years) and 68 females (27.87 %, 60.21±10.59 years). The primary diseases were cancer (43.44 %), cardiovascular disease (25.00 %), digestive system diseases, (18.44 %), infection (6.97 %), and nephropathy (6.15 %). Strains were isolated from the bloodstream (63.11 %), central venous catheters (15.16 %), pus (6.56 %), ascites (5.74 %), sterile body fluid (5.33 %), and bronchoalveolar lavage fluid (BALF, 4.09 %). Of the 244 C. parapsilosis complex strains, 179 (73.26 %) were identified as C. parapsilosis sensu stricto, 62 (25.41 %) were C. orthopsilosis, and three (1.23 %) were C. metapsilosis. Only one C. parapsilosis sensu stricto strain was resistant to anidulafungin, micafungin, caspofungin, and voriconazole, and it was non-wild-type (NWT) to amphotericin B. Furthermore, six C. parapsilosis sensu stricto strains were resistant to fluconazole, and one was dose-dependent susceptible. Five C. parapsilosis sensu stricto strains were NWT to posaconazole. Only one C. orthopsilosis strain was NWT for anidulafungin, micafungin, caspofungin, fluconazole, voriconazole, amphotericin B, and posaconazole, while the rest of the strains were wild-type.Conclusion.C. parapsilosis sensu stricto was the main clinical isolate from the C. parapsilosis complex in our hospital. Most strains were isolated from the bloodstream. The susceptibility rate to commonly used antifungal drugs was more than 96 %. Furthermore, most of the infected patients were elderly male cancer patients.
期刊介绍:
Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics